

MiniMed Group beat Q1 sales estimates with 16.6% growth to $843M; shares rose 7.1% as analysts raised price targets to $26-$28.
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still...
You can purchase shares of Minimed Group (NASDAQ:MMED) through any online brokerage.
Other companies in Minimed Group’s space includes: Alcon Inc (NYSE:ALC), Medline Inc (NASDAQ:MDLN), Solventum Corp (NYSE:SOLV), The Cooper Companies Inc (NASDAQ:COO) and Align Technology Inc (NASDAQ:ALGN).
Minimed Group has a consensus price target of $24.67.
The stock price for Minimed Group (NASDAQ: MMED) is $18.89 last updated November 16, 2026 at 10:32 AM EST.
There are no upcoming dividends for Minimed Group.
Minimed Group does not have any upcoming earnings scheduled.
There is no upcoming split for Minimed Group.
Minimed Group is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.